+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peptide Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 148 Pages
  • June 2024
  • Region: Global
  • TechNavio
  • ID: 5616563
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The peptide therapeutics market is forecasted to grow by USD 17.85 billion during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the peptide therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of infectious diseases, availability of favorable reimbursement policies, and drugs with extended half-life.

The peptide therapeutics market is segmented as below:

By Route Of Administration

  • Parenteral
  • Oral
  • Others

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the collaborations for R&D as one of the prime reasons driving the peptide therapeutics market growth during the next few years. Also, strong pipeline of peptide therapeutics and advent of novel technologies will lead to sizable demand in the market.

The report on the peptide therapeutics market covers the following areas:

  • Peptide therapeutics market sizing
  • Peptide therapeutics market forecast
  • Peptide therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading peptide therapeutics market vendors that include Almac Group Ltd., AmbioPharm Inc., Amgen Inc., AstraZeneca Plc, Bachem AG, Bristol Myers Squibb Co., Corden Pharma International GmbH, Eli Lilly and Co., Ever Pharma, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Ipsen Pharma, Lonza Group Ltd., Novartis AG, Novo Nordisk AS, PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Worg pharma. Also, the peptide therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Peptide Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Peptide Therapeutics Market 2018 - 2022 ($ billion)
4.2 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Route of Administration
6.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
6.3 Parenteral - Market size and forecast 2023-2028
Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
6.4 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ billion)
Data Table on Market opportunity by Route of Administration ($ billion)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity by geography
Market opportunity by geography ($ billion)
Data Tables on Market opportunity by geography ($ billion)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
11.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
11.5 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
11.6 Ever Pharma
Ever Pharma - Overview
Ever Pharma - Product / Service
Ever Pharma - Key offerings
11.7 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.8 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.9 Novo Nordisk AS
Novo Nordisk AS - Overview
Novo Nordisk AS - Business segments
Novo Nordisk AS - Key news
Novo Nordisk AS - Key offerings
Novo Nordisk AS - Segment focus
11.10 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.11 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
11.12 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
11.13 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Peptide Therapeutics Market 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 31: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Route of Administration
Exhibits 33: Data Table on Comparison by Route of Administration
Exhibits 34: Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Route of Administration ($ billion)
Exhibits 47: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits 48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 49: Chart on Market share by geography 2023-2028 (%)
Exhibits 50: Data Table on Market share by geography 2023-2028 (%)
Exhibits 51: Chart on Geographic comparison
Exhibits 52: Data Table on Geographic comparison
Exhibits 53: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 62: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 70: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 74: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 78: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 79: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 82: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 86: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 87: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 89: Market opportunity by geography ($ billion)
Exhibits 90: Data Tables on Market opportunity by geography ($ billion)
Exhibits 91: Impact of drivers and challenges in 2023 and 2028
Exhibits 92: Overview on criticality of inputs and factors of differentiation
Exhibits 93: Overview on factors of disruption
Exhibits 94: Impact of key risks on business
Exhibits 95: Companies covered
Exhibits 96: Matrix on companies position and classification
Exhibits 97: Amgen Inc. - Overview
Exhibits 98: Amgen Inc. - Product / Service
Exhibits 99: Amgen Inc. - Key news
Exhibits 100: Amgen Inc. - Key offerings
Exhibits 101: AstraZeneca Plc - Overview
Exhibits 102: AstraZeneca Plc - Product / Service
Exhibits 103: AstraZeneca Plc - Key news
Exhibits 104: AstraZeneca Plc - Key offerings
Exhibits 105: Eli Lilly and Co. - Overview
Exhibits 106: Eli Lilly and Co. - Product / Service
Exhibits 107: Eli Lilly and Co. - Key news
Exhibits 108: Eli Lilly and Co. - Key offerings
Exhibits 109: Ever Pharma - Overview
Exhibits 110: Ever Pharma - Product / Service
Exhibits 111: Ever Pharma - Key offerings
Exhibits 112: GlaxoSmithKline Plc - Overview
Exhibits 113: GlaxoSmithKline Plc - Business segments
Exhibits 114: GlaxoSmithKline Plc - Key news
Exhibits 115: GlaxoSmithKline Plc - Key offerings
Exhibits 116: GlaxoSmithKline Plc - Segment focus
Exhibits 117: Novartis AG - Overview
Exhibits 118: Novartis AG - Business segments
Exhibits 119: Novartis AG - Key news
Exhibits 120: Novartis AG - Key offerings
Exhibits 121: Novartis AG - Segment focus
Exhibits 122: Novo Nordisk AS - Overview
Exhibits 123: Novo Nordisk AS - Business segments
Exhibits 124: Novo Nordisk AS - Key news
Exhibits 125: Novo Nordisk AS - Key offerings
Exhibits 126: Novo Nordisk AS - Segment focus
Exhibits 127: Pfizer Inc. - Overview
Exhibits 128: Pfizer Inc. - Product / Service
Exhibits 129: Pfizer Inc. - Key news
Exhibits 130: Pfizer Inc. - Key offerings
Exhibits 131: Sanofi SA - Overview
Exhibits 132: Sanofi SA - Business segments
Exhibits 133: Sanofi SA - Key news
Exhibits 134: Sanofi SA - Key offerings
Exhibits 135: Sanofi SA - Segment focus
Exhibits 136: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 137: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 138: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 139: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 140: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 141: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 142: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 143: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 144: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 145: Inclusions checklist
Exhibits 146: Exclusions checklist
Exhibits 147: Currency conversion rates for US$
Exhibits 148: Research methodology
Exhibits 149: Information sources
Exhibits 150: Data validation
Exhibits 151: Validation techniques employed for market sizing
Exhibits 152: Data synthesis
Exhibits 153: 360 degree market analysis
Exhibits 154: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global peptide therapeutics market: Almac Group Ltd., AmbioPharm Inc., Amgen Inc., AstraZeneca Plc, Bachem AG, Bristol Myers Squibb Co., Corden Pharma International GmbH, Eli Lilly and Co., Ever Pharma, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Ipsen Pharma, Lonza Group Ltd., Novartis AG, Novo Nordisk AS, PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Worg pharma.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is collaborations for r and d."

According to the report, one of the major drivers for this market is the increasing prevalence of infectious diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Almac Group Ltd.
  • AmbioPharm Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bachem AG
  • Bristol Myers Squibb Co.
  • Corden Pharma International GmbH
  • Eli Lilly and Co.
  • Ever Pharma
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Ipsen Pharma
  • Lonza Group Ltd.
  • Novartis AG
  • Novo Nordisk AS
  • PeptiDream Inc.
  • Pfizer Inc.
  • PolyPeptide Group
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Worg pharma